Cell infusions benefit heart patients. – Brinkwire

More than three years after a clinical trial was prematurely ended for failing to show progress in healing heart attack scars, a prominent peer-reviewed journal is publishing some surprising results showing that the heart cell treatment does benefit patients.
Data from the ALLSTAR study published Tuesday by the European Heart Journal showed that although infusions of allogeneic cardiac cells-called cardiosphere-derived cells or CDCsdid not appear to shrink the scar left on heart muscle after a …

Click here to view the original article.